Novo Nordisk
NVO
#21
Rank
โ‚ฌ421.76 B
Marketcap
97,04ย โ‚ฌ
Share price
-2.85%
Change (1 day)
2.54%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚ฌ8.09 Billion

According to Novo Nordisk's latest financial reports the company's total debt is โ‚ฌ8.09 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Novo Nordisk - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚ฌ3.61 B4.52%
2022-12-31โ‚ฌ3.46 B-3.36%
2021-12-31โ‚ฌ3.58 B157.38%
2020-12-31โ‚ฌ1.39 B131.95%
2019-12-31โ‚ฌ0.60 B769.93%
2018-12-31โ‚ฌ68.97 M-69.7%
2017-12-31โ‚ฌ0.22 B638.37%
2016-12-31โ‚ฌ30.82 M-78.57%
2015-12-31โ‚ฌ0.14 B48.73%
2014-12-31โ‚ฌ96.69 M235.46%
2013-12-31โ‚ฌ28.82 M-57%
2012-12-31โ‚ฌ67.02 M-41.43%
2011-12-31โ‚ฌ0.11 B-61.65%
2010-12-31โ‚ฌ0.29 B59.89%
2009-12-31โ‚ฌ0.18 B-40.15%
2008-12-31โ‚ฌ0.31 B70.39%
2007-12-31โ‚ฌ0.18 B-10.07%
2006-12-31โ‚ฌ0.20 B-43.44%
2005-12-31โ‚ฌ0.35 B57.09%
2004-12-31โ‚ฌ0.22 B-1.59%
2003-12-31โ‚ฌ0.23 B21.97%
2002-12-31โ‚ฌ0.19 B-30.55%
2001-12-31โ‚ฌ0.27 B2.01%
2000-12-31โ‚ฌ0.26 B-5.92%
1999-12-31โ‚ฌ0.28 B-14.33%
1998-12-31โ‚ฌ0.33 B-11.13%
1997-12-31โ‚ฌ0.37 B35.06%
1996-12-31โ‚ฌ0.27 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚ฌ63.21 B 680.55%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ29.52 B 264.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ48.77 B 502.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ24.15 B 198.32%๐Ÿ‡ซ๐Ÿ‡ท France